- MyIllumina
- Tools
The TruSeq SBS Kit v5-GA has been optimized for the Genome Analyzer IIx system. With the TruSeq reagents, users can extend their read lengths to 2 x 150 and achieve up to 95 Gb of mappable data.
Ready-to-load reagents for use in the Genome Analyzer systems reduce hands-on preparation time to ten minutes. At read lengths of up to 100 bp, 80% of bases have quality scores (Q) in excess of 30, maximizing the ability to accurately characterize the genome and minimizing errors. The chemistry also delivers the highest yield of perfect reads. At read lengths of up to 100 bp, greater than 85% of reads map with no errors, giving scientists confidence to detect even rare events at lower coverage levels.
Catalog IDs: FC-104-5001
View the product support page for additional technical information ยป
Innovative technologies
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina's innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina's innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
© 2012 Illumina, Inc. All rights reserved.